{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:57:25Z","timestamp":1792180645075,"version":"4.4.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"This work was supported by nChroma Bio Inc. The funders of nChroma Bio had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Biomed. Eng"],"DOI":"10.1038\/s41551-026-01802-8","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:02:14Z","timestamp":1789981334000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Development of an investigational epigenetic silencer therapy to transcriptionally inactivate viral DNA in chronic hepatitis B"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6674-0595","authenticated-orcid":false,"given":"Yesseinia","family":"Anglero-Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1948-0772","authenticated-orcid":false,"given":"Martino Alfredo","family":"Cappelluti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah B.","family":"Voytek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen","family":"Acosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayman","family":"Choo-Wing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arogya","family":"Khadka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9927-3915","authenticated-orcid":false,"given":"Jhon A.","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Mugambwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Pantano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7724-6167","authenticated-orcid":false,"given":"Sivan","family":"Harel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5610-0172","authenticated-orcid":false,"given":"Amber","family":"DiPiazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7460-2771","authenticated-orcid":false,"given":"Sameer","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7625-8997","authenticated-orcid":false,"given":"Erica M.","family":"Hildebrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1259-5406","authenticated-orcid":false,"given":"Ricardo N.","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ava","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5568-5129","authenticated-orcid":false,"given":"Sahar","family":"Abubucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Wei","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Giancarlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley","family":"Niesner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3109-4073","authenticated-orcid":false,"given":"Matteo","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9153-9102","authenticated-orcid":false,"given":"Lorena","family":"Donnici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3608-2640","authenticated-orcid":false,"given":"Pietro","family":"Spinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taesun","family":"Eom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary S.","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4983-1801","authenticated-orcid":false,"given":"Ari E.","family":"Friedland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8754-5123","authenticated-orcid":false,"given":"Raffaele","family":"De Francesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8262-042X","authenticated-orcid":false,"given":"Angelo","family":"Lombardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vic E.","family":"Myer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6220-0476","authenticated-orcid":false,"given":"Aron B.","family":"Jaffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Bonner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2258-1953","authenticated-orcid":false,"given":"Jennifer L.","family":"Marlowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"1802_CR1","unstructured":"Global Hepatitis Report 2024: Action for Access in Low- and Middle-Income Countries https:\/\/www.who.int\/publications\/i\/item\/9789240091672 (WHO, 2024)."},{"key":"1802_CR2","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jhep.2021.11.024","volume":"76","author":"GLH Wong","year":"2022","unstructured":"Wong, G. L. H., Gane, E. & Lok, A. S. F. How to achieve functional cure of HBV: stopping NUCs, adding interferon or new drug development? J. Hepatol. 76, 1249\u20131262 (2022).","journal-title":"J. Hepatol."},{"key":"1802_CR3","doi-asserted-by":"publisher","first-page":"893512","DOI":"10.3389\/fimmu.2022.893512","volume":"13","author":"S Wu","year":"2022","unstructured":"Wu, S. et al. Immune mechanisms underlying hepatitis B surface antigen seroclearance in chronic hepatitis B patients with viral coinfection. Front. Immunol. 13, 893512 (2022).","journal-title":"Front. Immunol."},{"key":"1802_CR4","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00281-020-00780-6","volume":"42","author":"M Dandri","year":"2020","unstructured":"Dandri, M. Epigenetic modulation in chronic hepatitis B virus infection. Semin. Immunopathol. 42, 173\u2013185 (2020).","journal-title":"Semin. Immunopathol."},{"key":"1802_CR5","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1002\/jmv.21525","volume":"81","author":"Y Guo","year":"2009","unstructured":"Guo, Y., Li, Y., Mu, S., Zhang, J. & Yan, Z. Evidence that methylation of hepatitis B virus covalently closed circular DNA in liver tissues of patients with chronic hepatitis B modulates HBV replication. J. Me\u0301d. Virol. 81, 1177\u20131183 (2009).","journal-title":"J. Me\u0301d. Virol."},{"key":"1802_CR6","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1159\/000321450","volume":"54","author":"J-W Kim","year":"2011","unstructured":"Kim, J.-W. et al. Replicative activity of hepatitis B virus is negatively associated with methylation of covalently closed circular DNA in advanced hepatitis B virus infection. Intervirology 54, 316\u2013325 (2011).","journal-title":"Intervirology"},{"key":"1802_CR7","doi-asserted-by":"publisher","first-page":"e110442","DOI":"10.1371\/journal.pone.0110442","volume":"9","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y. et al. Transcription of hepatitis B virus covalently closed circular DNA is regulated by CpG methylation during chronic infection. PLoS ONE 9, e110442 (2014).","journal-title":"PLoS ONE"},{"key":"1802_CR8","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","volume":"67","author":"P Lampertico","year":"2017","unstructured":"Lampertico, P. et al. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J. Hepatol. 67, 370\u2013398 (2017).","journal-title":"J. Hepatol."},{"key":"1802_CR9","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3390\/v14040657","volume":"14","author":"M Moini","year":"2022","unstructured":"Moini, M. & Fung, S. HBsAg loss as a treatment endpoint for chronic HBV infection: HBV cure. Viruses 14, 657 (2022).","journal-title":"Viruses"},{"key":"1802_CR10","doi-asserted-by":"publisher","first-page":"593","DOI":"10.5009\/gnl240023","volume":"18","author":"ASF Lok","year":"2024","unstructured":"Lok, A. S. F. Toward a functional cure for hepatitis B. Gut Liver 18, 593\u2013601 (2024).","journal-title":"Gut Liver"},{"key":"1802_CR11","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1053\/j.gastro.2020.01.056","volume":"159","author":"Y-F Liaw","year":"2020","unstructured":"Liaw, Y.-F. Stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B. Gastroenterology 159, 1186 (2020).","journal-title":"Gastroenterology"},{"key":"1802_CR12","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s41575-022-00724-5","volume":"20","author":"SG Lim","year":"2023","unstructured":"Lim, S. G. et al. The scientific basis of combination therapy for chronic hepatitis B functional cure. Nat. Rev. Gastroenterol. Hepatol. 20, 238\u2013253 (2023).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1802_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2023.102112","volume":"35","author":"EM Smekalova","year":"2024","unstructured":"Smekalova, E. M. et al. Cytosine base editing inhibits hepatitis B virus replication and reduces HBsAg expression in vitro and in vivo. Mol. Ther. Nucleic Acids 35, 102112 (2024).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"1802_CR14","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1016\/j.ymthe.2022.05.013","volume":"30","author":"CL Gorsuch","year":"2022","unstructured":"Gorsuch, C. L. et al. Targeting the hepatitis B cccDNA with a sequence-specific ARCUS nuclease to eliminate hepatitis B virus in vivo. Mol. Ther. 30, 2909\u20132922 (2022).","journal-title":"Mol. Ther."},{"key":"1802_CR15","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1038\/s41591-025-03508-x","volume":"31","author":"F Tremblay","year":"2025","unstructured":"Tremblay, F. et al. A potent epigenetic editor targeting human PCSK9 for durable reduction of low-density lipoprotein cholesterol levels. Nat. Med. 31, 1329\u20131338 (2025).","journal-title":"Nat. Med."},{"key":"1802_CR16","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1093\/nar\/gkw1112","volume":"45","author":"P Stepper","year":"2017","unstructured":"Stepper, P. et al. Efficient targeted DNA methylation with chimeric dCas9\u2013Dnmt3a\u2013Dnmt3L methyltransferase. Nucleic Acids Res. 45, 1703\u20131713 (2017).","journal-title":"Nucleic Acids Res."},{"key":"1802_CR17","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1016\/j.cell.2021.03.025","volume":"184","author":"JK Nu\u00f1ez","year":"2021","unstructured":"Nu\u00f1ez, J. K. et al. Genome-wide programmable transcriptional memory by CRISPR-based epigenome editing. Cell 184, 2503\u20132519 (2021).","journal-title":"Cell"},{"key":"1802_CR18","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.cell.2016.09.006","volume":"167","author":"A Amabile","year":"2016","unstructured":"Amabile, A. et al. Inheritable silencing of endogenous genes by hit-and-run targeted epigenetic editing. Cell 167, 219\u2013232 (2016).","journal-title":"Cell"},{"key":"1802_CR19","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.cell.2013.02.022","volume":"152","author":"LS Qi","year":"2013","unstructured":"Qi, L. S. et al. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 152, 1173\u20131183 (2013).","journal-title":"Cell"},{"key":"1802_CR20","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/s41586-024-07087-8","volume":"627","author":"MA Cappelluti","year":"2024","unstructured":"Cappelluti, M. A. et al. Durable and efficient gene silencing in vivo by hit-and-run epigenome editing. Nature 627, 416\u2013423 (2024).","journal-title":"Nature"},{"key":"1802_CR21","doi-asserted-by":"publisher","first-page":"D566","DOI":"10.1093\/nar\/gks1022","volume":"41","author":"J Hayer","year":"2012","unstructured":"Hayer, J. et al. HBVdb: a knowledge database for hepatitis B Virus. Nucleic Acids Res. 41, D566\u2013D570 (2012).","journal-title":"Nucleic Acids Res."},{"key":"1802_CR22","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1073\/pnas.84.4.1005","volume":"84","author":"MA Sells","year":"1987","unstructured":"Sells, M. A., Chen, M. L. & Acs, G. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc. Natl Acad. Sci. USA 84, 1005\u20131009 (1987).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1802_CR23","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1515\/hsz-2018-0194","volume":"399","author":"R Essalmani","year":"2018","unstructured":"Essalmani, R. et al. A single domain antibody against the Cys- and His-rich domain of PCSK9 and evolocumab exhibit different inhibition mechanisms in humanized PCSK9 mice. Biol. Chem. 399, 1363\u20131374 (2018).","journal-title":"Biol. Chem."},{"key":"1802_CR24","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.3389\/fimmu.2018.02080","volume":"9","author":"H Li","year":"2018","unstructured":"Li, H. et al. Inhibition of HBV expression in HBV transgenic mice using AAV-delivered CRISPR\u2013SaCas9. Front. Immunol. 9, 2080 (2018).","journal-title":"Front. Immunol."},{"key":"1802_CR25","doi-asserted-by":"publisher","first-page":"6158","DOI":"10.1128\/jvi.69.10.6158-6169.1995","volume":"69","author":"LG Guidotti","year":"1995","unstructured":"Guidotti, L. G., Matzke, B., Schaller, H. & Chisari, F. V. High-level hepatitis B virus replication in transgenic mice. J. Virol. 69, 6158\u20136169 (1995).","journal-title":"J. Virol."},{"key":"1802_CR26","doi-asserted-by":"publisher","first-page":"1169770","DOI":"10.3389\/fmicb.2023.1169770","volume":"14","author":"H Guo","year":"2023","unstructured":"Guo, H., Urban, S. & Wang, W. In vitro cell culture models to study hepatitis B and D virus infection. Front. Microbiol. 14, 1169770 (2023).","journal-title":"Front. Microbiol."},{"key":"1802_CR27","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s12064-013-0178-3","volume":"132","author":"GP Wagner","year":"2013","unstructured":"Wagner, G. P., Kin, K. & Lynch, V. J. A model based criterion for gene expression calls using RNA-seq data. Theory Biosci. 132, 159\u2013164 (2013).","journal-title":"Theory Biosci."},{"key":"1802_CR28","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev.genom.7.080505.115623","volume":"7","author":"GA Maston","year":"2006","unstructured":"Maston, G. A., Evans, S. K. & Green, M. R. Transcriptional regulatory elements in the human genome. Genom. Hum. Genet. 7, 29\u201359 (2006).","journal-title":"Genom. Hum. Genet."},{"key":"1802_CR29","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1053\/j.gastro.2020.01.032","volume":"158","author":"T Michler","year":"2020","unstructured":"Michler, T. et al. Knockdown of virus antigen expression increases therapeutic vaccine efficacy in high-titer hepatitis B virus carrier mice. Gastroenterology 158, 1762\u20131775 (2020).","journal-title":"Gastroenterology"},{"key":"1802_CR30","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3390\/v16030347","volume":"16","author":"EV Gulck","year":"2024","unstructured":"Gulck, E. V. et al. Retreatment with HBV siRNA results in additional reduction in HBV antigenemia and immune stimulation in the AAV-HBV mouse model. Viruses 16, 347 (2024).","journal-title":"Viruses"},{"key":"1802_CR31","doi-asserted-by":"publisher","first-page":"102718","DOI":"10.1016\/j.omtn.2025.102718","volume":"36","author":"C Hua","year":"2025","unstructured":"Hua, C., Aftab, S., Rahaman, A., Abbas, Z. & Baloch, Z. siRNA approaches in HBV: from antigen reduction to seroconversion. Mol. Ther. Nucleic Acids 36, 102718 (2025).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"1802_CR32","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1056\/NEJMoa2210027","volume":"387","author":"M-F Yuen","year":"2022","unstructured":"Yuen, M.-F. et al. Efficacy and safety of bepirovirsen in chronic hepatitis B infection. N. Engl. J. Med. 387, 1957\u20131968 (2022).","journal-title":"N. Engl. J. Med."},{"key":"1802_CR33","doi-asserted-by":"publisher","DOI":"10.1172\/JCI163175","volume":"132","author":"MG Ghany","year":"2022","unstructured":"Ghany, M. G. & Lok, A. S. Functional cure of hepatitis B requires silencing covalently closed circular and integrated hepatitis B virus DNA. J. Clin. Investig. 132, e163175 (2022).","journal-title":"J. Clin. Investig."},{"key":"1802_CR34","doi-asserted-by":"publisher","DOI":"10.1172\/JCI148555","volume":"132","author":"K Musunuru","year":"2022","unstructured":"Musunuru, K. Moving toward genome-editing therapies for cardiovascular diseases. J. Clin. Investig. 132, e148555 (2022).","journal-title":"J. Clin. Investig."},{"key":"1802_CR35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2520814122","volume":"122","author":"I Miodownik","year":"2025","unstructured":"Miodownik, I. et al. DNA methylation shapes transcription factor binding beyond canonical CpG contexts. Proc. Natl Acad. Sci. USA 122, e2520814122 (2025).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1802_CR36","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1093\/nar\/gkac097","volume":"50","author":"S Li","year":"2022","unstructured":"Li, S., Peng, Y., Landsman, D. & Panchenko, A. R. DNA methylation cues in nucleosome geometry, stability and unwrapping. Nucleic Acids Res. 50, 1864\u20131874 (2022).","journal-title":"Nucleic Acids Res."},{"key":"1802_CR37","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1042\/BST20253094","volume":"53","author":"Y Pei","year":"2025","unstructured":"Pei, Y. & Li, G. Unraveling the interplay of DNA methylation and chromosome organization. Biochem. Soc. Trans. 53, 1433\u20131444 (2025).","journal-title":"Biochem. Soc. Trans."},{"key":"1802_CR38","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.02888-21","volume":"13","author":"MG Martinez","year":"2022","unstructured":"Martinez, M. G. et al. CRISPR\u2013Cas9 targeting of hepatitis B virus covalently closed circular DNA generates transcriptionally active episomal variants. Mbio 13, e02888-21 (2022).","journal-title":"Mbio"},{"key":"1802_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-62606-z","volume":"16","author":"C Aussel","year":"2025","unstructured":"Aussel, C., Cathomen, T. & Fuster-Garc\u00eda, C. The hidden risks of CRISPR\/Cas: structural variations and genome integrity. Nat. Commun. 16, 7208 (2025).","journal-title":"Nat. Commun."},{"key":"1802_CR40","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1186\/1471-2105-10-421","volume":"10","author":"C Camacho","year":"2009","unstructured":"Camacho, C. et al. BLAST+: architecture and applications. BMC Bioinform. 10, 421 (2009).","journal-title":"BMC Bioinform."},{"key":"1802_CR41","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1038\/mt.2013.124","volume":"21","author":"MA Maier","year":"2013","unstructured":"Maier, M. A. et al. Biodegradable lipids enabling rapidly eliminated lipid nanoparticles for systemic delivery of RNAi therapeutics. Mol. Ther. 21, 1570\u20131578 (2013).","journal-title":"Mol. Ther."},{"key":"1802_CR42","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s42826-019-0032-y","volume":"36","author":"C Tateno","year":"2020","unstructured":"Tateno, C. & Kojima, Y. Characterization and applications of chimeric mice with humanized livers for preclinical drug development. Lab. Anim. Res. 36, 2 (2020).","journal-title":"Lab. Anim. Res."},{"key":"1802_CR43","doi-asserted-by":"publisher","DOI":"10.3791\/64403","author":"A Migliara","year":"2023","unstructured":"Migliara, A. et al. In vitro selection of engineered transcriptional repressors for targeted epigenetic silencing. J. Vis. Exp. https:\/\/doi.org\/10.3791\/64403 (2023).","journal-title":"J. Vis. Exp."},{"key":"1802_CR44","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1093\/bioinformatics\/btr167","volume":"27","author":"F Krueger","year":"2011","unstructured":"Krueger, F. & Andrews, S. R. Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications. Bioinformatics 27, 1571\u20131572 (2011).","journal-title":"Bioinformatics"},{"key":"1802_CR45","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1038\/nprot.2013.132","volume":"8","author":"MH Larson","year":"2013","unstructured":"Larson, M. H. et al. CRISPR interference (CRISPRi) for sequence-specific control of gene expression. Nat. Protoc. 8, 2180\u20132196 (2013).","journal-title":"Nat. Protoc."},{"key":"1802_CR46","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2012","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2012).","journal-title":"Bioinformatics"},{"key":"1802_CR47","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-seq data with or without a reference genome. BMC Bioinform. 12, 323 (2011).","journal-title":"BMC Bioinform."},{"key":"1802_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"1802_CR49","doi-asserted-by":"publisher","first-page":"5524","DOI":"10.1093\/bioinformatics\/btaa1048","volume":"36","author":"A Mayakonda","year":"2020","unstructured":"Mayakonda, A. et al. Methrix: an R\/Bioconductor package for systematic aggregation and analysis of bisulfite sequencing data. Bioinformatics 36, 5524\u20135525 (2020).","journal-title":"Bioinformatics"},{"key":"1802_CR50","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1093\/nar\/gku154","volume":"42","author":"H Feng","year":"2014","unstructured":"Feng, H., Conneely, K. N. & Wu, H. A Bayesian hierarchical model to detect differentially methylated loci from single nucleotide resolution sequencing data. Nucleic Acids Res. 42, e69 (2014).","journal-title":"Nucleic Acids Res."},{"key":"1802_CR51","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1093\/biostatistics\/kxs033","volume":"14","author":"H Wu","year":"2013","unstructured":"Wu, H., Wang, C. & Wu, Z. A new shrinkage estimator for dispersion improves differential expression detection in RNA-seq data. Biostatistics 14, 232\u2013243 (2013).","journal-title":"Biostatistics"},{"key":"1802_CR52","first-page":"e141","volume":"43","author":"H Wu","year":"2015","unstructured":"Wu, H. et al. Detection of differentially methylated regions from whole-genome bisulfite sequencing data without replicates. Nucleic Acids Res. 43, e141 (2015).","journal-title":"Nucleic Acids Res."},{"key":"1802_CR53","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1093\/bioinformatics\/btw026","volume":"32","author":"Y Park","year":"2016","unstructured":"Park, Y. & Wu, H. Differential methylation analysis for BS-seq data under general experimental design. Bioinformatics 32, 1446\u20131453 (2016).","journal-title":"Bioinformatics"},{"key":"1802_CR54","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1109\/MCSE.2007.55","volume":"9","author":"JD Hunter","year":"2007","unstructured":"Hunter, J. D. Matplotlib: a 2D graphics environment. Comput. Sci. Eng. 9, 90\u201395 (2007).","journal-title":"Comput. Sci. Eng."},{"key":"1802_CR55","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.21105\/joss.03021","volume":"6","author":"M Waskom","year":"2021","unstructured":"Waskom, M. seaborn: statistical data visualization. J. Open Source Softw. 6, 3021 (2021).","journal-title":"J. Open Source Softw."}],"container-title":["Nature Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41551-026-01802-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-026-01802-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-026-01802-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:02:18Z","timestamp":1789981338000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41551-026-01802-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":55,"alternative-id":["1802"],"URL":"https:\/\/doi.org\/10.1038\/s41551-026-01802-8","relation":{},"ISSN":["2157-846X"],"issn-type":[{"value":"2157-846X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]},"assertion":[{"value":"11 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Q.X., S.B.V., L.H., A.K., C.M., S.H., S. Abraham., E.M.H., X.G., C.-W.K., T.E., M.B. and J.L.M. are employees of and hold an equity interest in nChroma Bio. Y.A.-R., R.C.-W., R.N.R., S. Abubucker, C.G., P.S., M.S.M., A.E.F. and V.E.M. hold an equity interest in nChroma Bio. A.L. is a cofounder of and holds an equity interest in nChroma Bio. The other authors declare no competing interests. nChroma Bio has filed for patent protection related to various aspects of ES of the HBV.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}